Implementation of an electronic genomic and family health history tool in primary prenatal care
Authors:
- Emily A. EdelmanEEEmily A. Edelman
- Bruce K. LinBLBruce K. Lin
- Teresa DoksumTDTeresa Doksum
- Brian DrohanBDBrian Drohan
- Vaughn EdelsonVEVaughn Edelson
- Siobhan M. DolanSDSiobhan M. Dolan
- Kevin S. HughesKHKevin S. Hughes
- James O'LEaryJOJames O'LEary
- Shelley L. GalvinSGShelley L. Galvin
- Nicole DeGroatNDNicole DeGroat
- Setul PardananiSPSetul Pardanani
- W. Gregory FeeroWFW. Gregory Feero
- 10 March 2014
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Vol. 166 (1) , 34-44
Abstract
“The Pregnancy and Health Profile,” (PHP) is a free genetic risk assessment software tool for primary prenatal providers that collects patient‐entered family (FHH), personal, and obstetrical health history, performs risk assessment, and presents the provider with clinical decision support during the prenatal encounter. The tool is freely available for download at www.hughesriskapps.net. We evaluated the implementation of PHP in four geographically diverse clinical sites. Retrospective chart reviews were conducted for patients seen prior to the study period and for patients who used the PHP to collect data on documentation of FHH, discussion of cystic fibrosis (CF) and hemoglobinopathy (HB) carrier screening, and CF and HB interventions (tests, referrals). Five hundred pre‐implementation phase and 618 implementation phase charts were reviewed. Documentation of a 3‐generation FHH or pedigree improved at three sites; patient race/ethnicity at three sites, father of the baby (FOB) race/ethnicity at all sites, and ancestry for the patient and FOB at three sites (P < 0.001–0001). CF counseling improved for implementation phase patients at one site (8% vs. 48%, P < 0.0001) and CF screening/referrals at two (2% vs. 14%, P < 0.0001; 6% vs. 14%; P = 0.05). Counseling and intervention rates did not increase for HB. This preliminary study suggests that the PHP can improve documentation of FHH, race, and ancestry, as well as the compliance with current CF counseling and intervention guidelines in some prenatal clinics. Future evaluation of the PHP should include testing in a larger number of clinical environments, assessment of additional performance measures, and evaluation of the system's overall clinical utility.Keywords
This publication has 23 references indexed in Scilit:
- Evaluation of a Novel Electronic Genetic Screening and Clinical Decision Support Tool in Prenatal Clinical SettingsMaternal and Child Health Journal, 2013
- Use of a Web-based Risk Appraisal Tool for Assessing Family History and Lifestyle Factors in Primary CareJournal of General Internal Medicine, 2013
- Cystic Fibrosis Carrier Screening in Obstetric Clinical Practice: Knowledge, Practices, and Barriers, a Decade After Publication of Screening GuidelinesGenetic Testing and Molecular Biomarkers, 2011
- Committee Opinion No. 486: Update on Carrier Screening for Cystic FibrosisObstetrics & Gynecology, 2011
- Committee Opinion No. 478: Family History as a Risk Assessment ToolObstetrics & Gynecology, 2011
- Committee Opinion No. 469: Carrier Screening for Fragile X SyndromeObstetrics & Gynecology, 2010
- ACOG Committee Opinion No. 442: Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish DescentObstetrics & Gynecology, 2009
- A Practical, Robust Implementation and Sustainability Model (PRISM) for Integrating Research Findings into PracticeThe Joint Commission Journal on Quality and Patient Safety, 2008
- ACOG Practice Bulletin No. 78: Hemoglobinopathies in PregnancyObstetrics & Gynecology, 2007
- Family history-taking in community family practice: Implications for genetic screeningGenetics in Medicine, 2000